Kobayashi Mami, Yagasaki Hideaki, Saito Tomohiro, Nemoto Atsushi, Naito Atsushi, Sugita Kanji
.
J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):1001-1005. doi: 10.1515/jpem-2017-0094.
Fetal goitrous hypothyroidism is mainly caused by maternal treatment of Graves' disease. Fetal goiter sometimes compresses the trachea and esophagus and may cause polyhydramnios, preterm labor, complications of labor and delivery, and neonatal respiratory disorder.
We report a case of fetal goitrous hypothyroidism in which the mother had Graves' disease, which was treated with propylthiouracil. Intra-amniotic levothyroxine (L-T4) administration was performed, and the fetal goiter decreased in size. A female infant was delivered without goiter and complications. Thyroid function was within the normal range.
Previous reports on fetal goitrous hypothyroidism that was treated with intra-amniotic L-T4 showed that patients who had intra-amniotic L-T4 administration were likely to have a good outcome compared with patients who did not have L-T4. Thyroid function of the mother and fetus should be carefully monitored and treated appropriately.
胎儿甲状腺肿性甲状腺功能减退主要由母亲的格雷夫斯病治疗引起。胎儿甲状腺肿有时会压迫气管和食管,并可能导致羊水过多、早产、分娩并发症及新生儿呼吸障碍。
我们报告一例胎儿甲状腺肿性甲状腺功能减退病例,其母亲患有格雷夫斯病,接受丙硫氧嘧啶治疗。进行了羊膜腔内左甲状腺素(L-T4)给药,胎儿甲状腺肿体积减小。一名女婴出生时无甲状腺肿及并发症。甲状腺功能在正常范围内。
既往关于羊膜腔内注射L-T4治疗胎儿甲状腺肿性甲状腺功能减退的报告显示,与未接受L-T4治疗的患者相比,接受羊膜腔内L-T4给药的患者可能有较好的结局。应仔细监测母亲和胎儿的甲状腺功能并进行适当治疗。